Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells

Energy metabolism in cancer cells is often increased to meet their higher proliferative rate and biosynthesis demands. Suppressing cancer cell metabolism using agents like metformin has become an attractive strategy for treating cancer patients. We showed that a novel ginsenoside derivative, Rh2E2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Vincent Kam Wai, Dong, Hang, Liang, Xu, Bai, Li-Ping, Jiang, Zhi-Hong, Guo, Yue, Kong, Ah-Ng Tony, Wang, Rui, Kam, Richard Kin Ting, Law, Betty Yuen Kwan, Hsiao, Wendy Wen Luen, Chan, Ka Man, Wang, Jingrong, Chan, Rick Wai Kit, Guo, Jianru, Zhang, Wei, Yen, Feng Gen, Zhou, Hua, Leung, Elaine Lai Han, Yu, Zhiling, Liu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891092/
https://www.ncbi.nlm.nih.gov/pubmed/26799418
http://dx.doi.org/10.18632/oncotarget.6934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891092/
https://www.ncbi.nlm.nih.gov/pubmed/26799418
http://dx.doi.org/10.18632/oncotarget.6934

Ejemplares similares